Dauden E, Gratacos J, Moreno JC, Gómez-Reino J, Rodríguez V, Sabater FJ, Casado MA
Health-related quality of life in patients with psoriatic arthritis
12th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Paris, France. 24-27 oct 2009
Dauden E, Gratacos J, Moreno JC, Gómez-Reino J, Rodríguez V, Sabater FJ, Casado MA
A cost-of-illness study of psoriatic arthritis in Spain
12th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Paris, France. 24-27 oct 2009
Puente J, Calderero V, García-Muro X, Trigo JM, Castro AJ, Martín-Escudero V, Yébenes M, Casado MA
Cost of managing adverse events in the treatment of first line metastasic renal cell carcinoma: bevacizumab + interferon alpha-2a compared with sunitinib in Spain
12th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Paris, France. 24-27 oct 2009
Seguí MA, Cortés J, Frias C, Oyagüez I, Casado MA
Evaluación económica de docetaxel versus paclitaxel semanal en pacientes con cáncer de mama metastásico en Españan
XII Congreso de la Sociedad Española de Oncología Médica (SEOM). Barcelona, España. 21-23 oct 2009
Puente J, Calderero V, García-Muro X, Trigo JM, Castro AJ, Martín-Escudero V, Yébenes M, Casado MA
Cost of managing adverse events in the treatment of first line metastasic renal cell carcinoma (mRCC): bevacizumab (BEV) + interferon alpha-2a (IFN) compared with sunitinib in Spain
XII Congreso de la Sociedad Española de Oncología Médica (SEOM). Barcelona, España. 21-23 oct 2009
Frias C, Cortés J, Seguí MA, Oyagüez I, Casado MA
Análisis coste-efectividad y coste-utilidad de docetaxel versus paclitaxel semanal en pacientes con cáncer de mama metastásico
54 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria (SEFH). Zaragoza, España. 22-25 sep 2009
Puente J, Calderero V, García-Muro X, Trigo JM, Castro AJ, Martín-Escudero V, Yébenes M, Casado MA
Costs of adverse events management associated to the treatment of first-line metastatic renal cell carcinoma with bevacizumab + interferon alpha-2a compared with sunitinib in Spain
34th Congress of the European Society for Medical Oncology (ESMO). Berlin, Germany. 20-24 sep 2009
Taxonera C, Calvet X, Gisbert JP, Rodrigo L, Bujanda L, Muñoz F, Ponce M, Gómez-Camacho F, Oyagüez I, Díaz-Rubio M, on behalf of COSCOL investigators
Unexpected follow-up surgeries related to failures in colectomy for ulcerative colitis
Digestive Disease Week (DDW). Chicago, Illinois. 30 may-4 jun 2009
Taxonera C, Calvet X, Gisbert JP, Rodrigo L, Bujanda L, Muñoz F, Ponce M, Gómez-Camacho F, Mendoza JL, Oyagüez I, Sabater FJ, on behalf of COSCOL study investigators